- Home
- NEOV vs CLYM Comparison
NEOV vs CLYM Comparison
Compare NEOV & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- CLYM
- Stock Information
- Founded
- NEOV 2018
- CLYM 2018
- Country
- NEOV United States
- CLYM United States
- Employees
- NEOV N/A
- CLYM N/A
- Industry
- NEOV Industrial Machinery/Components
- CLYM
- Sector
- NEOV Miscellaneous
- CLYM
- Exchange
- NEOV Nasdaq
- CLYM NYSE
- Market Cap
- NEOV 111.3M
- CLYM 101.6M
- IPO Year
- NEOV N/A
- CLYM 2021
- Fundamental
- Price
- NEOV $2.26
- CLYM $1.20
- Analyst Decision
- NEOV Strong Buy
- CLYM
- Analyst Count
- NEOV 1
- CLYM 0
- Target Price
- NEOV $7.50
- CLYM N/A
- AVG Volume (30 Days)
- NEOV 211.8K
- CLYM 168.2K
- Earning Date
- NEOV 05-09-2025
- CLYM 03-25-2025
- Dividend Yield
- NEOV N/A
- CLYM N/A
- EPS Growth
- NEOV N/A
- CLYM N/A
- EPS
- NEOV N/A
- CLYM N/A
- Revenue
- NEOV $2,524,931.00
- CLYM N/A
- Revenue This Year
- NEOV $85.10
- CLYM N/A
- Revenue Next Year
- NEOV $281.25
- CLYM N/A
- P/E Ratio
- NEOV N/A
- CLYM N/A
- Revenue Growth
- NEOV N/A
- CLYM N/A
- 52 Week Low
- NEOV $1.08
- CLYM $1.20
- 52 Week High
- NEOV $6.11
- CLYM $11.55
- Technical
- Relative Strength Index (RSI)
- NEOV 38.09
- CLYM N/A
- Support Level
- NEOV $2.32
- CLYM N/A
- Resistance Level
- NEOV $2.72
- CLYM N/A
- Average True Range (ATR)
- NEOV 0.33
- CLYM 0.00
- MACD
- NEOV -0.00
- CLYM 0.00
- Stochastic Oscillator
- NEOV 43.75
- CLYM 0.00
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.